505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA
Similar to 505(b)(2)
ACF - Administration for Children and FamiliesACG - American College of Gastroenterology
ACGME - Accreditation Council for Graduate Medical Education
ACIP - Advisory Committee on Immunization Practices CDC
ACLAD - American Committee on Laboratory Animal Diseases
ACLAM - American College of Laboratory Animal Medicine
ACMP - American College of Medical Physics
View all in FDA